Media
Podcasts, speaking engagements, interviews, and media mentions.
Coming September 2026
The Stakeholder Risk™ Podcast — long-form conversations on the risk no model prices.
Nona Biosciences · Next-Generation Biologics Forum
Jennifer G. Bates joins the investment panel on how biotechnology, academic, and investment leaders assess what they are actually underwriting.
Details →Co-authored by Jean Pineault and Juožas Gordevičius
A scientific paper on the widening gap between generating complex biological data and interpreting what it means for capital allocation and enterprise value. Executive summary and download available in Insights.
Details →Capital Allocators Podcast
A deep conversation on why human capital risk remains invisible in traditional diligence frameworks — and what leading sponsors are doing about it.
Private Equity International Conference
Keynote address on the structural gap between capital modeling and human execution risk in middle-market transactions.
CEO World Magazine
Interview exploring the patterns that cause governance failure to remain hidden until it becomes a value-destruction event.
Institutional Investor
Feature article examining the emergence of Stakeholder Risk as a formal discipline within private equity and large-cap advisory.
The Institutional Standard for Stakeholder Risk™
The primary driver of governance failure, execution breakdown, and enterprise value erosion in the middle market.
The institutions that price it early preserve optionality. Those that don't, absorb the cost at the capital event.